Advanced Adenocarcinoma Clinical Trials in Cleveland, Ohio
2 recruitingCleveland, Ohio
Showing 1–2 of 2 trials
Recruiting
Phase 1
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Advanced Adenocarcinoma
BioAtla, Inc.168 enrolled9 locationsNCT05808634
Recruiting
Phase 2
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
Siewert Type II Adenocarcinoma of Esophagogastric JunctionAdenocarcinoma EsophagusLocally Advanced Adenocarcinoma+1 more
Sakti Chakrabarti25 enrolled1 locationNCT06044311